Peer Reviewed


Document Type


Publication Date



Adenosine Triphosphate, Animals, Calcium Signaling, Glutamic Acid, Humans, Mitochondria, Molecular Imaging, N-Methylaspartate, Neurons, Receptors, AMPA


Science Foundation Ireland (08/IN.1/B1949; 13/IA/1881)


This is a pre-print of an article published in Journal of Bioenergetics and Biomembranes. The final authenticated version is available online at:


Excitotoxicity is a pathological process implicated in neuronal death during ischaemia, traumatic brain injuries and neurodegenerative diseases. Excitotoxicity is caused by excess levels of glutamate and over-activation of NMDA or calcium-permeable AMPA receptors on neuronal membranes, leading to ionic influx, energetic stress and potential neuronal death. The metabolic response of neurons to excitotoxicity is complex and plays a key role in the ability of the neuron to adapt and recover from such an insult. Single-cell imaging is a powerful experimental technique that can be used to study the neuronal metabolic response to excitotoxicity in vitro and, increasingly, in vivo. Here, we review some of the knowledge of the neuronal metabolic response to excitotoxicity gained from in vitro single-cell imaging, including calcium and ATP dynamics and their effects on mitochondrial function, along with the contribution of glucose metabolism, oxidative stress and additional neuroprotective signalling mechanisms. Future work will combine knowledge gained from single-cell imaging with data from biochemical and computational techniques to garner holistic information about the metabolic response to excitotoxicity at the whole brain level and transfer this knowledge to a clinical setting.


Physics | Physiology


Connolly NM, Prehn JH. The metabolic response to excitotoxicity - lessons from single-cell imaging. Journal of Bioenergetics and Biomembranes. 2015;47(1-2):75-88.

PubMed ID


DOI Link


Creative Commons License

Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-Share Alike 4.0 License.